Conference on Retroviruses & Opportunistic Infections

3-31-2020The 2020 Conference on Retroviruses and Opportunistic Infections (CROI) was convened as a virtual conference earlier this month. Each year, thousands of researc…

3-11-2020Cross-posted from NIAID NewsroomDolutegravir-containing regimen exhibited superior safety profile in large, NIH-supported study of pregnant women.The antiretrov…

3-9-2020Cross-posted from NIAID NewsroomAmong African adolescent girls and young women who took HIV pre-exposure prophylaxis (PrEP) daily, levels of the PrEP drug tenof…

3-9-2020Cross-posted from NIAID NewsroomA new approach to direct the body to make a specific antibody against HIV led to sustained production of that antibody for more …

3-4-2020HIV.gov will bring you live interviews on the latest developments in HIV research from CROI next week with NIH’s Dr. Carl Dieffenbach.

1-9-2020As 2020 begins, we pause to review and reflect upon our most-read posts of 2019.

3-12-2019Last week HIV.gov covered HIV research coming out of the 2019 Conference on Retroviruses and Opportunistic Infections.

3-8-2019Dr. Jonathan Mermin and Dr. Eugene McCray joined us to share highlights of some of the CDC-supported studies presented at the conference.

3-8-2019The findings from the  iENGAGE study underscore the benefits of linking people with HIV to treatment services soon after diagnosis.

3-7-2019Updates from CROI 2019: Promising advance in PrEP option, understanding HIV-associated inflammation, spreading the word about treatment as prevention and #U=U. …